5 August 2015 (Wednesday) - Daratumumab

On the one hand daratumumab is seen to be rather promising in the treatment of myeloma. On the other hand it (apparently) interferes in performing blood groups on automated systems as it causes panagglutination.

Apparently we are going to be involved in an international study.... I wonder how this will pan out

No comments:

Post a Comment